Talphera (TLPH) Competitors $0.64 +0.02 (+2.88%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TLPH vs. ALRN, VIRI, CDIO, BIVI, PASG, SNYR, DYAI, GANX, RLYB, and QTTBShould you be buying Talphera stock or one of its competitors? The main competitors of Talphera include Aileron Therapeutics (ALRN), Virios Therapeutics (VIRI), Cardio Diagnostics (CDIO), BioVie (BIVI), Passage Bio (PASG), Synergy CHC Corp. (Uplisting) (SNYR), Dyadic International (DYAI), Gain Therapeutics (GANX), Rallybio (RLYB), and Q32 Bio (QTTB). These companies are all part of the "pharmaceutical products" industry. Talphera vs. Aileron Therapeutics Virios Therapeutics Cardio Diagnostics BioVie Passage Bio Synergy CHC Corp. (Uplisting) Dyadic International Gain Therapeutics Rallybio Q32 Bio Aileron Therapeutics (NASDAQ:ALRN) and Talphera (NASDAQ:TLPH) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, community ranking, valuation, earnings and profitability. Is ALRN or TLPH more profitable? Aileron Therapeutics' return on equity of -74.08% beat Talphera's return on equity.Company Net Margins Return on Equity Return on Assets Aileron TherapeuticsN/A -74.08% -27.93% Talphera N/A -118.46%-65.82% Do analysts rate ALRN or TLPH? Aileron Therapeutics currently has a consensus target price of $19.00, indicating a potential upside of 985.71%. Talphera has a consensus target price of $4.50, indicating a potential upside of 608.33%. Given Aileron Therapeutics' higher probable upside, equities analysts plainly believe Aileron Therapeutics is more favorable than Talphera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aileron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Talphera 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has more risk and volatility, ALRN or TLPH? Aileron Therapeutics has a beta of 2.22, meaning that its stock price is 122% more volatile than the S&P 500. Comparatively, Talphera has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500. Does the media refer more to ALRN or TLPH? In the previous week, Aileron Therapeutics' average media sentiment score of 0.00 equaled Talphera'saverage media sentiment score. Company Overall Sentiment Aileron Therapeutics Neutral Talphera Neutral Does the MarketBeat Community favor ALRN or TLPH? Aileron Therapeutics received 207 more outperform votes than Talphera when rated by MarketBeat users. However, 100.00% of users gave Talphera an outperform vote while only 66.98% of users gave Aileron Therapeutics an outperform vote. CompanyUnderperformOutperformAileron TherapeuticsOutperform Votes21366.98% Underperform Votes10533.02% TalpheraOutperform Votes6100.00% Underperform VotesNo Votes Do institutionals & insiders have more ownership in ALRN or TLPH? 90.9% of Aileron Therapeutics shares are held by institutional investors. Comparatively, 37.7% of Talphera shares are held by institutional investors. 5.1% of Aileron Therapeutics shares are held by company insiders. Comparatively, 3.2% of Talphera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better valuation & earnings, ALRN or TLPH? Aileron Therapeutics has higher earnings, but lower revenue than Talphera. Talphera is trading at a lower price-to-earnings ratio than Aileron Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAileron TherapeuticsN/AN/A-$15.73M-$3.12-0.56Talphera$281K38.50-$18.40M-$0.69-0.92 SummaryAileron Therapeutics beats Talphera on 9 of the 12 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office... I put all the details together for you here — but please hurry. Get Talphera News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLPH vs. The Competition Export to ExcelMetricTalpheraPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.82M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E Ratio-0.9210.5991.3417.19Price / Sales38.50195.381,116.59116.80Price / CashN/A57.1642.6437.86Price / Book0.775.104.794.78Net Income-$18.40M$151.51M$120.07M$225.60M7 Day Performance-2.26%-2.15%-1.89%-1.24%1 Month Performance-9.14%-3.14%11.45%3.36%1 Year PerformanceN/A11.50%30.61%16.58% Talphera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLPHTalphera2.8883 of 5 stars$0.64+2.9%$4.50+608.3%N/A$10.82M$281,000.00-0.9219Positive NewsALRNAileron Therapeutics3.0762 of 5 stars$2.12-6.2%$19.00+796.2%-43.5%$45.93MN/A-0.699Positive NewsVIRIVirios TherapeuticsN/A$2.36-2.1%$3.00+27.1%+287.1%$45.45MN/A-8.745CDIOCardio Diagnostics2.663 of 5 stars$1.12-11.1%$2.00+78.6%-55.7%$45.29M$35,688.000.007Gap UpHigh Trading VolumeBIVIBioVie1.1668 of 5 stars$2.54-3.8%$3.00+18.1%+47.3%$45.13MN/A-0.2310PASGPassage Bio2.6946 of 5 stars$0.72-4.9%$7.75+973.4%-19.0%$44.60MN/A0.00130SNYRSynergy CHC Corp. (Uplisting)N/A$5.10-3.2%N/AN/A$44.39M$26.01M0.0040Positive NewsGap UpDYAIDyadic International1.6406 of 5 stars$1.49-8.6%$6.00+302.7%+12.2%$44.09M$3.36M-6.007Gap DownGANXGain Therapeutics2.4904 of 5 stars$1.65+1.4%$7.25+338.6%-36.1%$43.85M$50,000.00-1.4820RLYBRallybio2.7025 of 5 stars$1.03-4.6%$9.75+846.6%-65.5%$42.74MN/A-0.6740QTTBQ32 Bio2.8572 of 5 stars$3.50-5.4%$29.86+753.1%N/A$42.63M$-6,651,000.00-0.2439High Trading Volume Related Companies and Tools Related Companies Aileron Therapeutics Alternatives Virios Therapeutics Alternatives Cardio Diagnostics Alternatives BioVie Alternatives Passage Bio Alternatives Synergy CHC Corp. (Uplisting) Alternatives Dyadic International Alternatives Gain Therapeutics Alternatives Rallybio Alternatives Q32 Bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLPH) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLPH Stock Alerts